{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:45:41Z","timestamp":1767134741888,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":18,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001507.pub2","type":"reference-entry","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T07:13:50Z","timestamp":1280301230000},"source":"Crossref","is-referenced-by-count":6,"title":["Tyrosine supplementation for phenylketonuria"],"prefix":"10.1002","author":[{"given":"Diana","family":"Webster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Wildgoose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,4]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD001507.pub2-BIB1|cit1","first-page":"1261","article-title":"Cognition and tyrosine supplementation among school-aged children with phenylketonuria","volume":"146","author":"Mazzocco","year":"1992","journal-title":"American Journal of Diseases of Children"},{"issue":"6","key":"10.1002\/14651858.CD001507.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0022-3476(95)70031-5","article-title":"Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria","volume":"127","author":"Pietz","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD001507.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/adc.78.2.116","article-title":"Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria","volume":"78","author":"Smith","year":"1998","journal-title":"Archives of Disease in Childhood"},{"issue":"9","key":"10.1002\/14651858.CD001507.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1651-2227.2005.tb02078.x","article-title":"Behavioural effects of phenylalanine-free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria","volume":"94","author":"Kalkanoglu","year":"2005","journal-title":"Acta Paediatrica"},{"issue":"4","key":"10.1002\/14651858.CD001507.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1651-2227.1987.tb10521.x","article-title":"Increased vigilance and dopomine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria","volume":"76","author":"Lou","year":"1987","journal-title":"Acta Paediatrica Scandanavia"},{"issue":"3","key":"10.1002\/14651858.CD001507.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00441411","article-title":"Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine","volume":"148","author":"Lykkelund","year":"1988","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD001507.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/adc.88.4.327","article-title":"Are tablets a practical source of protein substitute in phenylketonuria?","volume":"88","author":"MacDonald","year":"2003","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"10.1002\/14651858.CD001507.pub2-BIB8|cit8","first-page":"417","article-title":"Case studies of the effect of tyrosine administration in children with phenylketonuria on cognitive processes","volume":"204","author":"Wasser","year":"1992","journal-title":"Klinische Padiatrie"},{"issue":"2","key":"10.1002\/14651858.CD001507.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1440-1754.1997.tb01031.x","article-title":"Tyrosine supplementation in phenylketonuria [letter]","volume":"33","author":"Lines","year":"1997","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD001507.pub2-BIB10|cit10","first-page":"177","article-title":"Disorders of amino acid metabolism, organic acidaemias and uria cycle defects","volume-title":"Clinical Paediatric Dietetics","author":"Dixon","year":"1994"},{"issue":"1","key":"10.1002\/14651858.CD001507.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analysis involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD001507.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00491918","article-title":"Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents","volume":"144","author":"Lou","year":"1985","journal-title":"European Journal of Pediatrics"},{"issue":"6870","key":"10.1002\/14651858.CD001507.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/bmj.306.6870.115","article-title":"Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story","volume":"306","year":"1993","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD001507.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/adc.68.3.426","article-title":"Recommendations on the dietary management of phenylketonuria","volume":"68","year":"1993","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD001507.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneur.1973.00490190063008","article-title":"Saturation of blood brain barrier transport of amino acids in phenylketonuria","volume":"28","author":"Oldendorf","year":"1973","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD001507.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1542\/peds.20.2.290","article-title":"The variability and manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria)","volume":"20","author":"Paine","year":"1957","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD001507.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD001507.pub2-BIB18|cit18","first-page":"1015","article-title":"The hyperphenylalaninaemias","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Scriver","year":"1995"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001507.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001507.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T07:50:33Z","timestamp":1740297033000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001507.pub2"}},"subtitle":[],"editor":[{"given":"Diana","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001507.pub2","relation":{},"subject":[],"published":{"date-parts":[[2010,8,4]]}}}